Works by Nagasawa, Takashi

Results: 60
    1
    2
    3

    Reliability of Telepsychiatry Assessments Using the Attention-Deficit/Hyperactivity Disorder Rating Scale-IV for Children With Neurodevelopmental Disorders and Their Caregivers: Randomized Feasibility Study.

    Published in:
    Journal of Medical Internet Research, 2024, v. 26, p. 1, doi. 10.2196/51749
    By:
    • Kurokawa, Shunya;
    • Nomura, Kensuke;
    • Hosogane, Nana;
    • Nagasawa, Takashi;
    • Kawade, Yuko;
    • Matsumoto, Yu;
    • Morinaga, Shuichi;
    • Kaise, Yuriko;
    • Higuchi, Ayana;
    • Goto, Akiko;
    • Inada, Naoko;
    • Kodaira, Masaki;
    • Kishimoto, Taishiro
    Publication type:
    Article
    4
    5
    6
    7

    New niches for B cells.

    Published in:
    Nature Immunology, 2008, v. 9, n. 4, p. 345, doi. 10.1038/ni0408-345
    By:
    • Nagasawa, Takashi
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Identification of CXCL12‐abundant reticular cells in human adult bone marrow.

    Published in:
    British Journal of Haematology, 2021, v. 193, n. 3, p. 659, doi. 10.1111/bjh.17396
    By:
    • Aoki, Kazunari;
    • Kurashige, Masako;
    • Ichii, Michiko;
    • Higaki, Kei;
    • Sugiyama, Tatsuki;
    • Kaito, Takashi;
    • Ando, Wataru;
    • Sugano, Nobuhiko;
    • Sakai, Takashi;
    • Shibayama, Hirohiko;
    • Takaori‐Kondo, Akifumi;
    • Morii, Eiichi;
    • Kanakura, Yuzuru;
    • Nagasawa, Takashi
    Publication type:
    Article
    14
    15
    16
    17
    18

    An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia.

    Published in:
    Neuropsychiatric Disease & Treatment, 2013, v. 9, p. 1553, doi. 10.2147/NDT.S46108
    By:
    • Jinichi Hirano;
    • Koichiro Watanabe;
    • Takefumi Suzuki;
    • Hiroyuki Uchida;
    • Ryosuke Den;
    • Taishiro Kishimoto;
    • Takashi Nagasawa;
    • Yusuke Tomita;
    • Koichiro Hara;
    • Hiromi Ochi;
    • Yoshimi Kobayashi;
    • Mutsuko Ishii;
    • Akane Fujita;
    • Yoshihiko Kanai;
    • Megumi Goto;
    • Hiromi Hayashi;
    • Kanako Inamura;
    • Fumiko Ooshima;
    • Mariko Sumida;
    • Tomoko Ozawa
    Publication type:
    Article
    19
    20

    Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study.

    Published in:
    Cancer Science, 2020, v. 111, n. 10, p. 3726, doi. 10.1111/cas.14576
    By:
    • Seto, Takashi;
    • Hayashi, Hidetoshi;
    • Satouchi, Miyako;
    • Goto, Yasushi;
    • Niho, Seiji;
    • Nogami, Naoyuki;
    • Hida, Toyoaki;
    • Takahashi, Toshiaki;
    • Sakakibara‐Konishi, Jun;
    • Morise, Masahiro;
    • Nagasawa, Takashi;
    • Suzuki, Mie;
    • Ohkura, Masayuki;
    • Fukuhara, Kei;
    • Thurm, Holger;
    • Peltz, Gerson;
    • Nishio, Makoto
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 262, doi. 10.1007/s10147-018-1359-3
    By:
    • Masuda, Norikazu;
    • Inoue, Kenichi;
    • Nakamura, Rikiya;
    • Rai, Yoshiaki;
    • Mukai, Hirofumi;
    • Ohno, Shinji;
    • Hara, Fumikata;
    • Mori, Yuko;
    • Hashigaki, Satoshi;
    • Muramatsu, Yasuaki;
    • Nagasawa, Takashi;
    • Umeyama, Yoshiko;
    • Huang, Xin;
    • Iwata, Hiroji
    Publication type:
    Article
    38

    Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 274, doi. 10.1007/s10147-018-1353-9
    By:
    • Mukai, Hirofumi;
    • Shimizu, Chikako;
    • Masuda, Norikazu;
    • Ohtani, Shoichiro;
    • Ohno, Shinji;
    • Takahashi, Masato;
    • Yamamoto, Yutaka;
    • Nishimura, Reiki;
    • Sato, Nobuaki;
    • Ohsumi, Shozo;
    • Iwata, Hiroji;
    • Mori, Yuko;
    • Hashigaki, Satoshi;
    • Muramatsu, Yasuaki;
    • Nagasawa, Takashi;
    • Umeyama, Yoshiko;
    • Lu, Dongrui R.;
    • Toi, Masakazu
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.

    Published in:
    Breast Cancer (13406868), 2022, v. 29, n. 6, p. 1088, doi. 10.1007/s12282-022-01390-w
    By:
    • Kotani, Haruru;
    • Masuda, Norikazu;
    • Yamashita, Toshinari;
    • Naito, Yoichi;
    • Taira, Tetsuhiko;
    • Inoue, Kenichi;
    • Takahashi, Masato;
    • Yonemori, Kan;
    • Toyoizumi, Shigeyuki;
    • Mori, Yuko;
    • Nagasawa, Takashi;
    • Hori, Natsuki;
    • Iwata, Hiroji
    Publication type:
    Article
    50